CL2021002080A1 - Composición para su uso en el tratamiento de la piscirickettsiosis. - Google Patents

Composición para su uso en el tratamiento de la piscirickettsiosis.

Info

Publication number
CL2021002080A1
CL2021002080A1 CL2021002080A CL2021002080A CL2021002080A1 CL 2021002080 A1 CL2021002080 A1 CL 2021002080A1 CL 2021002080 A CL2021002080 A CL 2021002080A CL 2021002080 A CL2021002080 A CL 2021002080A CL 2021002080 A1 CL2021002080 A1 CL 2021002080A1
Authority
CL
Chile
Prior art keywords
composition
piscirickettsiosis
treatment
poikilotherms
mcfa
Prior art date
Application number
CL2021002080A
Other languages
English (en)
Inventor
Geert Bruggeman
Roland Brugger
Original Assignee
Nutrition Sciences Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nutrition Sciences Nv filed Critical Nutrition Sciences Nv
Publication of CL2021002080A1 publication Critical patent/CL2021002080A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/174—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/20—Inorganic substances, e.g. oligoelements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/80—Feeding-stuffs specially adapted for particular animals for aquatic animals, e.g. fish, crustaceans or molluscs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K61/00—Culture of aquatic animals
    • A01K61/10—Culture of aquatic animals of fish
    • A01K61/13—Prevention or treatment of fish diseases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
    • Y02A40/80—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in fisheries management
    • Y02A40/81—Aquaculture, e.g. of fish

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Polymers & Plastics (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Insects & Arthropods (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Birds (AREA)
  • Communicable Diseases (AREA)
  • Fodder In General (AREA)
  • Feed For Specific Animals (AREA)

Abstract

La presente invención permite obtener una composición para uso en el tratamiento, la supresión y/o la prevención de la piscirickettsiosis, de preferencia en poiquilotermos acuáticos, donde la composición comprende uno o más ácidos grasos de cadena media (MCFA) y/o sus derivados.
CL2021002080A 2019-02-08 2021-08-05 Composición para su uso en el tratamiento de la piscirickettsiosis. CL2021002080A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BE20195082A BE1027041B1 (nl) 2019-02-08 2019-02-08 Samenstelling voor gebruik bij de behandeling van piscirickettsiose

Publications (1)

Publication Number Publication Date
CL2021002080A1 true CL2021002080A1 (es) 2022-01-21

Family

ID=66439821

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2021002080A CL2021002080A1 (es) 2019-02-08 2021-08-05 Composición para su uso en el tratamiento de la piscirickettsiosis.

Country Status (4)

Country Link
EP (1) EP3920902A1 (es)
BE (1) BE1027041B1 (es)
CL (1) CL2021002080A1 (es)
WO (1) WO2020161349A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024003035A1 (en) * 2022-06-27 2024-01-04 Vaxxinova Norway As Vaccines for piscirickettsiosis (salmonid rickettsial septicaemia)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3829105A1 (de) 1988-08-27 1990-03-08 Chiron Werke Gmbh Werkzeugmaschine
JP2831835B2 (ja) * 1990-10-23 1998-12-02 花王株式会社 養魚用飼料
DE69928276D1 (de) * 1998-08-25 2005-12-15 Nippon Suisan Kaisha Ltd Verwendung natürlicher physiologisch aktiver substanzen gegen parasitäre fischerkrankungen
NO20100454A1 (no) * 2010-03-26 2011-09-27 Ewos Innovation As Forbindelse og sammensetning for kontroll av bakterier og virus
WO2015052672A1 (en) * 2013-10-09 2015-04-16 Nutrition Sciences N.V. Composition of medium-chain fatty acids and feed supplemented with composition
US20180325970A1 (en) * 2016-07-29 2018-11-15 Saponin Research Center S.A. Use of quillaja saponaria extracts for the prevention and control of bacterial infections in fish

Also Published As

Publication number Publication date
EP3920902A1 (en) 2021-12-15
BE1027041A1 (nl) 2020-09-01
WO2020161349A1 (en) 2020-08-13
BE1027041B1 (nl) 2020-09-08

Similar Documents

Publication Publication Date Title
CO2020009625A2 (es) Inhibidor de fap
CO2020010303A2 (es) Conjugados de il-15, y sus usos
CL2021003191A1 (es) Inhibidores de tead y usos de los mismos
CL2021003190A1 (es) Inhibidores de tead y usos de los mismos
AR118540A2 (es) Composiciones de esporas bacterianas para uso industrial
CL2022001670A1 (es) Inhibidores de proteínas kras mutantes
CO2019000135A2 (es) Composiciones que comprenden cepas bacterianas
PE20151894A1 (es) Composiciones y metodos de variantes de inhibidor tisular de la metaloproteinasa tipo tres (timp 3)
ECSP11010746A (es) Salicilatos acetilados con ácidos grasos y sus usos
CL2011000527A1 (es) Compuestos derivados de benzofurano; composicion farmaceutica que los comprende;y su uso en el tratamiento de la hepatitis c.
CL2009000178A1 (es) Composicion que comprende un anticuerpo contra el dominio ii de her2, sus variantes acidas, secuencias que comprenden las cadenas livianas y pesadas de este; formulacion farmaceutica que comprende dicho anticuerpo y uso de este para cancer her2 positivo.
RS54261B1 (en) USE OF SGC STIMULATORS, SGC ACTIVATORS, INDIVIDUALLY AND IN COMBINATION WITH PDE5 INHIBITORS FOR SYSTEMIC SCLEROSIS TREATMENT (SSC)
CL2013001338A1 (es) Compuestos derivados de benzotieno-piridinas sustituidas, inhibidores de la replicacion del vih; composicion farmaceutica que los comprende; combinacion farmaceutica; kit farmaceutico; y su uso para el tratamiento del vih.
AR113490A1 (es) CONSTRUCCIONES DE ARNi PARA INHIBIR LA EXPRESIÓN DE PNPLA3 Y MÉTODOS DE USO DE LAS MISMAS
GT200600463A (es) Derivados de carbamoilbenzotriazol como inhibidores de lipasas y fosfolipasas
CL2019003402A1 (es) Composiciones sólidas para administración oral.
MX2021004999A (es) Administracion de butirato, beta-hidroxibutirato, cannabidiol y compuestos relacionaods en seres humanos.
CO2021003530A2 (es) Conjugados de interleuquina 10 y usos de los mismos
CL2015000608A1 (es) Formulaciones de daptomicina y usos de la misma
CL2021000855A1 (es) Replicones basados en alfavirus para la administración de bioterapias.
CO2021014835A2 (es) Ácidos grasos poliinsaturados de cadena muy larga, derivados hidroxilados elovanoides y métodos de uso
CO2017002813A2 (es) Derivados estabilizados de adrenomedulina y uso de los mismos
CL2021002080A1 (es) Composición para su uso en el tratamiento de la piscirickettsiosis.
CL2022000967A1 (es) Composiciones y métodos para el tratamiento de enfermedades hepáticas
CO2021007006A2 (es) Moduladores de la expresión de irf5